Patents by Inventor Sheng-Tien LI

Sheng-Tien LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-B7-H4 CONSTRUCTS AND USES THEREOF
    Publication number: 20230112085
    Abstract: The present application provides anti-B7-H4 constructs that bind to B7-H4 (e.g., anti-B7-H4 antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-B7-H4, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-B7-H4 construct, pharmaceutical compositions containing the anti-B7-H4 construct, and methods of using the anti-B7-H4 construct or compositions.
    Type: Application
    Filed: January 29, 2021
    Publication date: April 13, 2023
    Inventors: Li-Fen LEE, Kan LU, Jessica YU, Sheng-Tien LI, Julie HUANG
  • METHODS AND COMPOSITIONS FOR TREATING CANCER OR VIRAL INFECTION WITH A PLA2G2D ANTAGONIST
    Publication number: 20230075779
    Abstract: The present application provides methods of treating a disease (such as cancer or infectious disease) that involves an antagonist that targets PLA2G2D signaling pathway (such as an antagonist that targets PLA2G2D. The present application also provides non-naturally occurring PLA2G2D polypeptides.
    Type: Application
    Filed: January 29, 2021
    Publication date: March 9, 2023
    Applicant: Apeximmune Therapeutics Inc.
    Inventors: Li-Fen LEE, Kan LU, Jessica YU, Sheng-Tien LI, Julie HUANG, Katharine YU